The Company's proprietary SMARTT Polymer Technology™ is based on novel synthetic, multi-functional polymers exclusively licensed from the University of Washington. These rights, and others which we own or control, reinforce our position as the leader in using functional and pH-responsive polymeric carriers for the delivery of biomolecular therapeutics.
Our Intellectual property portfolio includes:
•15 patent families filed in the world's major pharmaceutical markets•4 issued U.S. patents
•Over 60 pending applications
Our Intellectual property rights cover:
•Novel polymer compositions and intermediates•Novel formulations
•Specific combinations of polymers with therapeutics
© 2011 PhaseRx, Inc. 410 West Harrison Street, Suite 300, Seattle WA 98119 206.805.6300 Terms of Use Site Design